Your provider will discuss whether compounded therapy is appropriate for your goals and health profile during your consult
Funding The author(s) declared that financial support was received for this work and/or its publication
IV therapy supplies potent antioxidants that shield and revitalize these cells
If you're on a 1ml weekly protocol and seeing no measurable change after six weeks, the problem is almost never 'too low a dose.' It's either formulation quality (underdosed methionine or choline), dietary interference (you're in maintenance calories, not deficit), or liver saturation (you're already consuming high dietary methionine and adding more doesn't shift the pathway further)
Abstract Obesity rates, once thought to be on an inevitable rise with limited treatment options, have recently stabilized and begun to decline in the US, a trend that coincides with the increased use of GLP-1 receptor agonist medications for weight management
Obesity is a major driver of US health care costs, totaling almost $173 billion annually, according to the CDC in 2024